Beyond Turkey? Take Home Triple-Digit Gains This Holiday

---

Story Highlights:

• Meatless foods market: $4.2 million.
• Projected growth: $5.8 billion by 2022.
• Investment potential: See triple-digit gains in a year with this play on the meatless-food trend.

---

Happy Thanksgiving, Bold Profits Nation!

At the risk of offending my dear mother this Thanksgiving, I have a confession to make:

I don’t much care for turkey. I prefer the side dishes that accompany the traditional Turkey Day bird.

Garlic mashed potatoes. Asparagus amandine. Cornbread-and-chestnut stuffing. Candied yams.

These vegan staples are what really get my taste buds dancing at the Thanksgiving table. And, it turns out, I’m not the only one.

Market research shows that turkey has become the latest casualty of the growing meatless-food trend. Millions of Americans are turning to plant-based protein alternatives to poultry, as well as beef and pork.

Some are even predicting this year’s Thanksgiving will be the biggest ever for meatless alternatives.

A recent Nielsen report on plant-based food sales also found that meat substitutes for holiday meals grew 6% last year, to $555 million — and that figure is rising.

Even uber chefs like Martha Stewart are hopping on the meatless-holiday bandwagon. Stewart recently spotlighted “meatless Thanksgiving mains” on her website.

These developments are only the latest indication that millions are embracing meatless alternatives to burgers, steaks, pork chops and poultry.

As a result, Thanksgiving meals are changing in ways the Pilgrims and Native Americans could never have imagined.

And that’s phenomenal news for biotech investors who recognize the investment potential the mounting meatless market presents.

Today, I’m going to tell you two ways to leverage it with investments that could have you giving thanks for years to come — regardless of whether a turkey graces your holiday table today.

Serve Yourself a Portion of the Meatless Market’s 57% Boom

The Beyond Meat boom isn’t going anywhere.

Here are a few tasty statistics to share with your friends or family as you pass around the potatoes, stuffing and pumpkin pie this Thanksgiving:

• A recent Johns Hopkins survey found 64% are buying less meat, 42% are eating more meatless meals and 32% are choosing to have meatless days.
• The global meat-substitutes market will hit $5.8 billion by 2022 — a 57% rise since 2016 and up from $4.2 million last year, Grand View Research reports.
• Millennials are driving this trend, with 47% of Americans born between 1980 and 2000 more likely than the average U.S. consumer to incorporate plant-based foods into their diets, Nielson reports.

One dramatic example of the investment potential is the rise of Beyond Meat, one of the meatless industry’s biggest superstars.

The California-based producer of plant-based meat alternatives made from soy and pea protein ignited the industry when it went public in May. Within weeks, its stock price skyrocketed 800%.

Beyond Meat’s stock is still up from its IPO, but has been falling. So I’m not recommending you buy in right now.

A better way is to add an exchange-traded fund (ETF) to your portfolio. And today, I have two options for you:

• The Renaissance IPO ETF (NYSE: IPO) is a great play on IPOs that the Bold Profits team has identified as a terrific way to tap the white-hot market. It’s a basket of companies that recently went public and are listed on a U.S. exchange. The ETF holds assets of more than $30 million and is up more than 25% year to date.
• Another option is to buy into a new vegan-themed ETF that hit the New York Stock Exchange in September: U.S. Vegan Climate ETF (NYSE: VEGN). It holds shares of newly public protein-substitute makers, including Beyond Meat, and other vegan-market leaders. It also excludes companies that harm animals, are involved in animal testing or produce animal-derived products.

Both ETFs give you a relatively safe way to play the meatless market.

And maybe next year, our table will feature a Beyond Meat Turkey for our Thanksgiving dinner.

Until next week.

To your health and wealth,

Nick Tate

Senior Editorial Manager, Banyan Hill Publishing

from Timor Invest https://ift.tt/2OuSOwd